D Ketley

Author PubWeight™ 8.93^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Influencing sceptical staff to become supporters of service improvement: a qualitative study of doctors' and managers' views.	Qual Saf Health Care	2004	1.87
2	Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group.	Eur Heart J	1998	1.73
3	Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective.	Eur Heart J	1998	1.45
4	Thrombolysis and acute myocardial infarction.	Lancet	1994	0.89
5	Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals.	Int J Cardiol	1997	0.79
6	Clinical effects of anticoagulants in suspected acute myocardial infarction. Use of anticoagulants in suspected acute myocardial infarction in Europe varies.	BMJ	1997	0.75
7	Intravenous beta blockade in acute myocardial infarction. Doubts exist about external validity of trials of intravenous beta blockade.	BMJ	1999	0.75
8	Agism and provision of thrombolysis.	BMJ	1995	0.75
9	Utilisation of thrombolytic therapy in older patients with myocardial infarction.	Drugs Aging	1998	0.75
10	Involving quality review nurses in pharmacy-based drug-use evaluation program.	Am J Hosp Pharm	1989	0.75
11	Reformulated Omnopon.	BMJ	1992	0.75